2025
|
P/S
|
diagnostic agents, namely, tracer agents for use with medical monitoring equipment; tracer agent ... |
2024
|
Invention
|
Intrinsic fluorescence generation using exogenous fluorescence agent. Method, system, and apparat... |
|
Invention
|
Intrinsic fluorescence generation using exogenous fluorescence agent.
Method, system, and appara... |
|
P/S
|
Diagnostic agents, namely, tracer agents for use with medical monitoring equipment; tracer agent ... |
|
P/S
|
Diagnostic agents, namely, tracer agents for use with
medical monitoring equipment; tracer agent... |
|
P/S
|
diagnostic agents, namely, tracer agents for diagnostic imaging for use with medical monitoring e... |
|
Invention
|
Method for non-invasive monitoring of fluorescent tracer agent with diffuse reflecting medium wit... |
2023
|
Invention
|
Synthesis of substituted pyrazines.
Described herein are methods to form substituted pyrazines. ... |
|
Invention
|
Synthesis and purification of substituted pyrazines. Described herein are methods to form substit... |
|
Invention
|
Compositions and systems for renal function determination.
The present disclosure relates to sys... |
|
Invention
|
Methods for renal function determination.
A method for determining a glomerular filtration rate ... |
|
Invention
|
Sensor |
|
Invention
|
Sensor ring |
2022
|
P/S
|
downloadable mobile applications for remote monitoring of medical tracer agents administered in h... |
|
Invention
|
Methods of monitoring mucosal healing.
The disclosure provides for methods for monitoring mucosa... |
|
Invention
|
Methods of monitoring mucosal healing. The disclosure provides for methods for monitoring mucosal... |
|
Invention
|
Preparation of substituted diaminopyrazine dicarboxylic acids.
The present invention provides im... |
|
Invention
|
Purification of substituted diaminopyrazine dicarboxylic acids. The present invention provides me... |
|
Invention
|
Purification of substituted diaminopyrazine dicarboxylic acids.
The present invention provides m... |
|
Invention
|
Preparation of substituted diaminopyrazine dicarboxylic acids. The present invention provides imp... |
|
P/S
|
Medical devices, namely, devices for detecting tracer agents and monitoring physiological function. |
|
P/S
|
Medical devices, namely, devices for detecting tracer agents
and monitoring physiological function. |
|
Invention
|
Compositions and methods for assessing gut function. Compositions and methods for assessing gut f... |
|
Invention
|
Two piece sensor assembly and method of use.
Disclosed herein is a two-piece sensor assembly tha... |
|
Invention
|
Fluorescent pyrazine derivatives and methods of using the same in assessing renal function.
The ... |
2021
|
Invention
|
Subcutaneous and intramuscular administration of pyrazine compounds. The present disclosure relat... |
|
Invention
|
Subcutaneous and intramuscular administration of pyrazine compounds.
The present disclosure rela... |
|
Invention
|
Compositions and methods for assessing eye vasculature.
Compositions and methods for assessing b... |
|
Invention
|
Method for preparing 3,6-diaminopyrazine-2,5-dicarboxylic acid and synthetic intermediate thereof... |
|
P/S
|
medical devices, namely, devices for detecting tracer agents and monitoring physiological function |
|
Invention
|
Transcutaneous organ function measurement. The present invention relates to a method for determin... |
|
Invention
|
Systems and methods for home transdermal assessment of gastrointestinal function. Disclosed herei... |
|
Invention
|
Sensor assembly with movable skin sensor.
Disclosed herein is a housing assembly configured to a... |
|
Invention
|
Sensor assembly with movable skin sensor. Disclosed herein is a housing assembly configured to at... |
|
P/S
|
Medical devices, namely, devices for detecting fluorescent
tracer agents in animals and monitori... |
|
P/S
|
Medical devices, namely, devices for detecting fluorescent tracer agents in animals and monitorin... |
|
P/S
|
Diagnostic agents, namely, tracer agents for medical photonic diagnostic imaging purposes. |
|
P/S
|
Diagnostic agents, namely, tracer agents for medical
diagnostic imaging purposes. |
2020
|
Invention
|
Anodic oxidation of 5-aminouracil. A process for preparing pyrimido[4,5-g]pteridine-2,4,7,9-tetra... |
|
Invention
|
Anodic oxidation of 5-aminouracil. ggg]pteridine-2,4,7,9-tetraol, or a salt thereof, is further p... |
|
Invention
|
Sensor head for non-invasive monitoring of a fluorescent tracer agent. A sensor head is provided.... |
|
Invention
|
Transcutaneous organ function measurement. A sensor plaster (116) for the transcutaneous measurem... |
|
P/S
|
Diagnostic agents, namely, tracer agents for medical
diagnostic imaging purposes. Medical device... |
|
P/S
|
Diagnostic agents, namely, tracer agents for medical photonic diagnostic imaging purposes
Medical... |
|
P/S
|
Veterinary apparatus for detecting fluorescent tracer agents in animals and monitoring physiologi... |
|
P/S
|
Veterinary apparatus for detecting fluorescent tracer agents
in animals and monitoring physiolog... |
|
P/S
|
Fluorescent tracer agent for use with medical monitoring equipment; fluorescent tracer agent for ... |
|
P/S
|
Fluorescent tracer agent for use with medical monitoring
equipment; fluorescent tracer agent for... |
|
P/S
|
diagnostic agents, namely, tracer agents for medical diagnostic imaging purposes |
|
P/S
|
diagnostic agents, namely, tracer agents for medical diagnostic imaging purposes medical devices,... |
2019
|
Invention
|
Method for non-invasive monitoring of fluorescent tracer agent with diffuse reflection correction... |
|
Invention
|
Compositions and methods for assessing eye vasculature. Compositions and methods for assessing bl... |
|
Invention
|
Systems and methods for home transdermal gfr monitoring. Disclosed herein is a non-transitory com... |
|
Invention
|
Systems and methods for home transdermal gfr monitoring.
Disclosed herein is a non-transitory co... |
|
Invention
|
Two piece sensor assembly and method of use. Disclosed herein is a two-piece sensor assembly that... |
|
Invention
|
Uses of transdermal glomerular filtration rate measurement in continuous renal replacement therap... |
|
P/S
|
medical devices, namely, devices for detecting fluorescent tracer agents in animals and monitorin... |
|
Invention
|
Tissue sealant compositions, vascular closure devices, and uses thereof. The present invention pr... |
|
Invention
|
Compositions and methods for assessing eye vasculature.
The present disclosure relates to compos... |
2017
|
P/S
|
fluorescent tracer agent for use with medical monitoring equipment; fluorescent tracer agent for ... |
|
P/S
|
Diagnostic agents, namely, tracer agents for medical diagnostic imaging purposes |